Symbol:
Slc6a15
Name:
solute carrier family 6 member 15
RGD ID:
628664
Description:
Predicted to enable branched-chain amino acid:sodium symporter activity; neutral L-amino acid:sodium symporter activity; and proline:sodium symporter activity. Predicted to be involved in L-leucine transport; proline transport; and sodium ion transmembrane transport. Predicted to be located in membrane. Predicted to be active in plasma membrane. Orthologous to human SLC6A15 (solute carrier family 6 member 15); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; ammonium chloride; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Ntt73; orphan sodium- and chloride-dependent neurotransmitter transporter NTT73; orphan transporter v7-3; sodium- and chloride-dependent neurotransmitter transporter NTT73; sodium-dependent neutral amino acid transporter B(0)AT2; solute carrier family 6 (neurotransmitter transporter), member 15; solute carrier family 6 (neutral amino acid transporter), member 15; transporter v7-3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC6A15 (solute carrier family 6 member 15)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Slc6a15 (solute carrier family 6 (neurotransmitter transporter), member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc6a15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC6A15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC6A15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc6a15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC6A15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC6A15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc6a15 (solute carrier family 6 member 15)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
UBXN1 (UBX domain protein 1)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
SLC6A15 (solute carrier family 6 member 15)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Slc6a15 (solute carrier family 6 (neurotransmitter transporter), member 15)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc6a15 (solute carrier family 6 member 15)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG10804
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Drosophila melanogaster (fruit fly):
CG43066
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
slc6a15
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 40,439,607 - 40,493,788 (+) NCBI GRCr8 mRatBN7.2 7 38,553,055 - 38,607,239 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 38,553,196 - 38,607,239 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 40,490,690 - 40,544,721 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 42,693,756 - 42,747,787 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 42,468,678 - 42,522,713 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 45,328,207 - 45,381,920 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 45,328,105 - 45,382,229 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 45,348,955 - 45,402,668 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 41,498,013 - 41,552,028 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 41,518,322 - 41,572,299 (+) NCBI Celera 7 35,501,267 - 35,556,333 (+) NCBI Celera Cytogenetic Map 7 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc6a15 Rat (+)-catechin multiple interactions ISO RGD:735866 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SLC6A15 mRNA CTD PMID:24763279 Slc6a15 Rat (2,4,5-trichlorophenoxy)acetic acid decreases expression ISO RGD:735867 6480464 2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of SLC6A15 mRNA CTD PMID:18579281 Slc6a15 Rat 1,1-dichloroethene decreases expression ISO RGD:735867 6480464 vinylidene chloride results in decreased expression of SLC6A15 mRNA CTD PMID:26682919 Slc6a15 Rat 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO RGD:735867 6480464 [Citalopram co-treated with Caffeine] results in decreased expression of SLC6A15 mRNA CTD PMID:29107002 Slc6a15 Rat 17beta-estradiol increases expression ISO RGD:735866 6480464 Estradiol results in increased expression of SLC6A15 mRNA CTD PMID:36828454 Slc6a15 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735867 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A15 mRNA CTD PMID:21570461 Slc6a15 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A15 mRNA CTD PMID:33387578 Slc6a15 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:735866 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of SLC6A15 mRNA CTD PMID:26705709 Slc6a15 Rat 2-palmitoylglycerol increases expression ISO RGD:735866 6480464 2-palmitoylglycerol results in increased expression of SLC6A15 mRNA CTD PMID:37199045 Slc6a15 Rat aflatoxin B1 decreases methylation ISO RGD:735866 6480464 Aflatoxin B1 results in decreased methylation of SLC6A15 gene CTD PMID:27153756 Slc6a15 Rat agomelatine multiple interactions ISO RGD:735867 6480464 [Caffeine co-treated with agomelatine] results in decreased expression of SLC6A15 mRNA CTD PMID:29882086 Slc6a15 Rat all-trans-retinoic acid decreases expression ISO RGD:735866 6480464 Tretinoin results in decreased expression of SLC6A15 mRNA CTD PMID:23724009 Slc6a15 Rat all-trans-retinoic acid multiple interactions ISO RGD:735867 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC6A15 mRNA CTD PMID:36189433 Slc6a15 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC6A15 mRNA CTD PMID:16483693 Slc6a15 Rat aristolochic acid A decreases expression ISO RGD:735866 6480464 aristolochic acid I results in decreased expression of SLC6A15 mRNA CTD PMID:33212167 Slc6a15 Rat benzo[a]pyrene decreases expression ISO RGD:735867 6480464 Benzo(a)pyrene results in decreased expression of SLC6A15 mRNA CTD PMID:22228805 Slc6a15 Rat benzo[a]pyrene affects methylation ISO RGD:735866 6480464 Benzo(a)pyrene affects the methylation of SLC6A15 5' UTR; Benzo(a)pyrene affects the methylation of SLC6A15 promoter CTD PMID:27901495 Slc6a15 Rat benzo[a]pyrene increases methylation ISO RGD:735866 6480464 Benzo(a)pyrene results in increased methylation of SLC6A15 exon CTD PMID:27901495 Slc6a15 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:735867 6480464 [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of SLC6A15 mRNA CTD PMID:31606821 Slc6a15 Rat bisphenol A decreases expression ISO RGD:735866 6480464 bisphenol A results in decreased expression of SLC6A15 mRNA CTD PMID:20678512 Slc6a15 Rat bisphenol A multiple interactions ISO RGD:735866 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A15 gene CTD PMID:31601247 Slc6a15 Rat bisphenol A increases methylation ISO RGD:735866 6480464 bisphenol A results in increased methylation of SLC6A15 gene CTD PMID:31601247 Slc6a15 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC6A15 gene CTD PMID:28505145 Slc6a15 Rat bisphenol A increases expression ISO RGD:735866 6480464 bisphenol A results in increased expression of SLC6A15 mRNA CTD PMID:27685785|PMID:29275510|PMID:36828454 Slc6a15 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A15 mRNA CTD PMID:25181051|PMID:31129395 Slc6a15 Rat bleomycin A2 decreases expression ISO RGD:735867 6480464 Bleomycin results in decreased expression of SLC6A15 mRNA CTD PMID:30825431 Slc6a15 Rat bleomycin A2 multiple interactions ISO RGD:735867 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC6A15 mRNA]; lenabasum inhibits more ... CTD PMID:30825431 Slc6a15 Rat butanal increases expression ISO RGD:735866 6480464 butyraldehyde results in increased expression of SLC6A15 mRNA CTD PMID:26079696 Slc6a15 Rat cadmium dichloride decreases expression ISO RGD:735866 6480464 Cadmium Chloride results in decreased expression of SLC6A15 mRNA CTD PMID:38568856 Slc6a15 Rat caffeine multiple interactions ISO RGD:735867 6480464 [Caffeine co-treated with agomelatine] results in decreased expression of SLC6A15 mRNA; [Caffeine co-treated with Mianserin] more ... CTD PMID:29107002|PMID:29882086 Slc6a15 Rat cannabidiol multiple interactions ISO RGD:735867 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC6A15 mRNA] CTD PMID:30825431 Slc6a15 Rat chloroprene increases expression ISO RGD:735867 6480464 Chloroprene results in increased expression of SLC6A15 mRNA CTD PMID:23125180 Slc6a15 Rat cisplatin multiple interactions ISO RGD:735866 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SLC6A15 mRNA] CTD PMID:21858171 Slc6a15 Rat cisplatin decreases expression ISO RGD:735866 6480464 Cisplatin results in decreased expression of SLC6A15 mRNA CTD PMID:27392435 Slc6a15 Rat citalopram multiple interactions ISO RGD:735867 6480464 [Citalopram co-treated with Caffeine] results in decreased expression of SLC6A15 mRNA CTD PMID:29107002 Slc6a15 Rat copper(II) sulfate decreases expression ISO RGD:735867 6480464 Copper Sulfate results in decreased expression of SLC6A15 mRNA CTD PMID:18579281 Slc6a15 Rat corticosterone multiple interactions ISO RGD:735867 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA]; Paroxetine inhibits the more ... CTD PMID:31344373 Slc6a15 Rat corticosterone decreases expression ISO RGD:735867 6480464 Corticosterone results in decreased expression of SLC6A15 mRNA CTD PMID:31344373 Slc6a15 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC6A15 mRNA CTD PMID:26577399 Slc6a15 Rat cyclosporin A decreases methylation ISO RGD:735866 6480464 Cyclosporine results in decreased methylation of SLC6A15 promoter CTD PMID:27989131 Slc6a15 Rat dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC6A15 mRNA CTD PMID:18636392 Slc6a15 Rat diquat decreases expression ISO RGD:735867 6480464 Diquat results in decreased expression of SLC6A15 mRNA CTD PMID:36851058 Slc6a15 Rat dorsomorphin multiple interactions ISO RGD:735866 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc6a15 Rat edaravone multiple interactions ISO RGD:735867 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA] CTD PMID:31344373 Slc6a15 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC6A15 mRNA CTD PMID:29391264 Slc6a15 Rat fenfluramine increases expression ISO RGD:735866 6480464 Fenfluramine results in increased expression of SLC6A15 mRNA CTD PMID:22140631 Slc6a15 Rat fluoxetine multiple interactions ISO RGD:735867 6480464 [Fluoxetine co-treated with Caffeine] results in decreased expression of SLC6A15 mRNA CTD PMID:29107002 Slc6a15 Rat folic acid decreases expression ISO RGD:735867 6480464 Folic Acid results in decreased expression of SLC6A15 mRNA CTD PMID:25629700 Slc6a15 Rat FR900359 affects phosphorylation ISO RGD:735866 6480464 FR900359 affects the phosphorylation of SLC6A15 protein CTD PMID:37730182 Slc6a15 Rat fulvestrant multiple interactions ISO RGD:735866 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A15 gene CTD PMID:31601247 Slc6a15 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC6A15 mRNA CTD PMID:33387578 Slc6a15 Rat hydrazine decreases expression ISO RGD:735867 6480464 hydrazine results in decreased expression of SLC6A15 mRNA CTD PMID:15282401 Slc6a15 Rat Licochalcone B decreases expression ISO RGD:735866 6480464 licochalcone B results in decreased expression of SLC6A15 mRNA CTD PMID:33647349 Slc6a15 Rat mercury dibromide decreases expression ISO RGD:735866 6480464 mercuric bromide results in decreased expression of SLC6A15 mRNA CTD PMID:26272509 Slc6a15 Rat mercury dibromide multiple interactions ISO RGD:735866 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc6a15 Rat methylmercury chloride decreases expression ISO RGD:735866 6480464 methylmercuric chloride results in decreased expression of SLC6A15 mRNA CTD PMID:23179753|PMID:27188386 Slc6a15 Rat methylmercury chloride increases expression ISO RGD:735866 6480464 methylmercuric chloride results in increased expression of SLC6A15 mRNA CTD PMID:28001369 Slc6a15 Rat mianserin multiple interactions ISO RGD:735867 6480464 [Caffeine co-treated with Mianserin] results in decreased expression of SLC6A15 mRNA CTD PMID:29882086 Slc6a15 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:735867 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC6A15 mRNA CTD PMID:36189433 Slc6a15 Rat N-methyl-4-phenylpyridinium increases expression ISO RGD:735866 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A15 mRNA CTD PMID:24810058 Slc6a15 Rat okadaic acid decreases expression ISO RGD:735866 6480464 Okadaic Acid results in decreased expression of SLC6A15 mRNA CTD PMID:38832940 Slc6a15 Rat ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC6A15 mRNA CTD PMID:18636392 Slc6a15 Rat ozone multiple interactions ISO RGD:735867 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC6A15 more ... CTD PMID:34911549 Slc6a15 Rat paracetamol increases expression ISO RGD:735867 6480464 Acetaminophen results in increased expression of SLC6A15 mRNA CTD PMID:17585979 Slc6a15 Rat paroxetine multiple interactions ISO RGD:735867 6480464 Paroxetine inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA] CTD PMID:31344373 Slc6a15 Rat PD 0325901 multiple interactions ISO RGD:735866 6480464 [mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of SLC6A15 mRNA CTD PMID:25119042 Slc6a15 Rat PD 0325901 decreases expression ISO RGD:735866 6480464 mirdametinib results in decreased expression of SLC6A15 mRNA CTD PMID:25119042 Slc6a15 Rat pentanal increases expression ISO RGD:735866 6480464 pentanal results in increased expression of SLC6A15 mRNA CTD PMID:26079696 Slc6a15 Rat perfluorooctane-1-sulfonic acid increases expression ISO RGD:735866 6480464 perfluorooctane sulfonic acid results in increased expression of SLC6A15 mRNA CTD PMID:36864359 Slc6a15 Rat perfluorooctanoic acid increases expression ISO RGD:735866 6480464 perfluorooctanoic acid results in increased expression of SLC6A15 mRNA CTD PMID:37302725 Slc6a15 Rat phenylmercury acetate decreases expression ISO RGD:735866 6480464 Phenylmercuric Acetate results in decreased expression of SLC6A15 mRNA CTD PMID:26272509 Slc6a15 Rat phenylmercury acetate multiple interactions ISO RGD:735866 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc6a15 Rat pioglitazone multiple interactions ISO RGD:735867 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC6A15 mRNA CTD PMID:27935865 Slc6a15 Rat piroxicam multiple interactions ISO RGD:735866 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SLC6A15 mRNA] CTD PMID:21858171 Slc6a15 Rat piroxicam decreases expression ISO RGD:735866 6480464 Piroxicam results in decreased expression of SLC6A15 mRNA CTD PMID:21858171 Slc6a15 Rat potassium chromate increases expression ISO RGD:735866 6480464 potassium chromate(VI) results in increased expression of SLC6A15 mRNA CTD PMID:22714537 Slc6a15 Rat propanal increases expression ISO RGD:735866 6480464 propionaldehyde results in increased expression of SLC6A15 mRNA CTD PMID:26079696 Slc6a15 Rat sarin decreases expression ISO RGD:735866 6480464 Sarin results in decreased expression of SLC6A15 mRNA CTD PMID:19522546 Slc6a15 Rat SB 431542 multiple interactions ISO RGD:735866 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc6a15 Rat silicon dioxide increases expression ISO RGD:735866 6480464 Silicon Dioxide analog results in increased expression of SLC6A15 mRNA CTD PMID:25895662 Slc6a15 Rat silicon dioxide decreases expression ISO RGD:735866 6480464 Silicon Dioxide results in decreased expression of SLC6A15 mRNA CTD PMID:25351596 Slc6a15 Rat silver atom decreases expression ISO RGD:735867 6480464 Silver results in decreased expression of SLC6A15 mRNA CTD PMID:27131904 Slc6a15 Rat silver(0) decreases expression ISO RGD:735867 6480464 Silver results in decreased expression of SLC6A15 mRNA CTD PMID:27131904 Slc6a15 Rat sodium arsenite decreases expression ISO RGD:735866 6480464 sodium arsenite results in decreased expression of SLC6A15 mRNA CTD PMID:38568856 Slc6a15 Rat sodium arsenite decreases expression ISO RGD:735867 6480464 sodium arsenite results in decreased expression of SLC6A15 mRNA CTD PMID:37682722 Slc6a15 Rat sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of SLC6A15 mRNA CTD PMID:27257137 Slc6a15 Rat streptozocin increases expression ISO RGD:735867 6480464 Streptozocin results in increased expression of SLC6A15 mRNA CTD PMID:31606821 Slc6a15 Rat streptozocin multiple interactions ISO RGD:735867 6480464 [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of SLC6A15 mRNA CTD PMID:31606821 Slc6a15 Rat temozolomide decreases expression ISO RGD:735866 6480464 Temozolomide results in decreased expression of SLC6A15 mRNA CTD PMID:31758290 Slc6a15 Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of SLC6A15 mRNA CTD PMID:21515302 Slc6a15 Rat thiram decreases expression ISO RGD:735866 6480464 Thiram results in decreased expression of SLC6A15 mRNA CTD PMID:38568856 Slc6a15 Rat titanium dioxide decreases expression ISO RGD:735867 6480464 titanium dioxide results in decreased expression of SLC6A15 mRNA CTD PMID:29264374 Slc6a15 Rat titanium dioxide decreases methylation ISO RGD:735867 6480464 titanium dioxide results in decreased methylation of SLC6A15 promoter CTD PMID:35295148 Slc6a15 Rat tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of SLC6A15 mRNA CTD PMID:31129395 Slc6a15 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC6A15 mRNA CTD PMID:33387578 Slc6a15 Rat trichostatin A increases expression ISO RGD:735866 6480464 trichostatin A results in increased expression of SLC6A15 mRNA CTD PMID:24935251 Slc6a15 Rat triclosan increases expression ISO RGD:735866 6480464 Triclosan results in increased expression of SLC6A15 mRNA CTD PMID:30510588 Slc6a15 Rat valproic acid affects expression ISO RGD:735866 6480464 Valproic Acid affects the expression of SLC6A15 mRNA CTD PMID:23179753|PMID:25979313 Slc6a15 Rat valproic acid decreases expression ISO RGD:735866 6480464 Valproic Acid results in decreased expression of SLC6A15 mRNA CTD PMID:28001369 Slc6a15 Rat valproic acid increases expression ISO RGD:735866 6480464 Valproic Acid results in increased expression of SLC6A15 mRNA CTD PMID:24935251|PMID:27188386 Slc6a15 Rat vorinostat multiple interactions ISO RGD:735866 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Slc6a15 Rat vorinostat increases expression ISO RGD:735866 6480464 vorinostat results in increased expression of SLC6A15 mRNA CTD PMID:26272509 Slc6a15 Rat zearalenone increases expression ISO RGD:735866 6480464 Zearalenone results in increased expression of SLC6A15 mRNA CTD PMID:36828454
(+)-catechin (ISO) (2,4,5-trichlorophenoxy)acetic acid (ISO) 1,1-dichloroethene (ISO) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2-palmitoylglycerol (ISO) aflatoxin B1 (ISO) agomelatine (ISO) all-trans-retinoic acid (ISO) ammonium chloride (EXP) aristolochic acid A (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bleomycin A2 (ISO) butanal (ISO) cadmium dichloride (ISO) caffeine (ISO) cannabidiol (ISO) chloroprene (ISO) cisplatin (ISO) citalopram (ISO) copper(II) sulfate (ISO) corticosterone (ISO) Cuprizon (EXP) cyclosporin A (ISO) dichlorine (EXP) diquat (ISO) dorsomorphin (ISO) edaravone (ISO) endosulfan (EXP) fenfluramine (ISO) fluoxetine (ISO) folic acid (ISO) FR900359 (ISO) fulvestrant (ISO) gentamycin (EXP) hydrazine (ISO) Licochalcone B (ISO) mercury dibromide (ISO) methylmercury chloride (ISO) mianserin (ISO) mono(2-ethylhexyl) phthalate (ISO) N-methyl-4-phenylpyridinium (ISO) okadaic acid (ISO) ozone (EXP,ISO) paracetamol (ISO) paroxetine (ISO) PD 0325901 (ISO) pentanal (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) phenylmercury acetate (ISO) pioglitazone (ISO) piroxicam (ISO) potassium chromate (ISO) propanal (ISO) sarin (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium fluoride (EXP) streptozocin (ISO) temozolomide (ISO) Tesaglitazar (EXP) thiram (ISO) titanium dioxide (ISO) tributylstannane (EXP) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) valproic acid (ISO) vorinostat (ISO) zearalenone (ISO)
Slc6a15 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 40,439,607 - 40,493,788 (+) NCBI GRCr8 mRatBN7.2 7 38,553,055 - 38,607,239 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 38,553,196 - 38,607,239 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 40,490,690 - 40,544,721 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 42,693,756 - 42,747,787 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 42,468,678 - 42,522,713 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 45,328,207 - 45,381,920 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 45,328,105 - 45,382,229 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 45,348,955 - 45,402,668 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 41,498,013 - 41,552,028 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 41,518,322 - 41,572,299 (+) NCBI Celera 7 35,501,267 - 35,556,333 (+) NCBI Celera Cytogenetic Map 7 q21 NCBI
SLC6A15 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 84,859,491 - 84,912,799 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 84,859,491 - 84,913,629 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 85,253,270 - 85,306,578 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 83,777,398 - 83,830,705 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 83,777,098 - 83,809,042 NCBI Celera 12 84,916,853 - 84,970,192 (-) NCBI Celera Cytogenetic Map 12 q21.31 NCBI HuRef 12 82,310,425 - 82,363,775 (-) NCBI HuRef CHM1_1 12 85,218,075 - 85,271,562 (-) NCBI CHM1_1 T2T-CHM13v2.0 12 84,838,955 - 84,892,203 (-) NCBI T2T-CHM13v2.0
Slc6a15 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 10 103,203,320 - 103,255,240 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 10 103,203,644 - 103,255,238 (+) Ensembl GRCm39 Ensembl GRCm38 10 103,367,808 - 103,419,379 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 10 103,367,783 - 103,419,377 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 10 102,830,477 - 102,882,011 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 10 102,797,531 - 102,849,065 (+) NCBI MGSCv36 mm8 Celera 10 105,308,965 - 105,360,380 (+) NCBI Celera Cytogenetic Map 10 D1 NCBI cM Map 10 53.98 NCBI
Slc6a15 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955405 22,821,835 - 22,875,398 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955405 22,821,931 - 22,846,420 (-) NCBI ChiLan1.0 ChiLan1.0
SLC6A15 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 92,905,140 - 92,962,305 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 92,905,335 - 92,958,703 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 82,379,018 - 82,432,243 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 85,481,700 - 85,534,716 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 85,463,088 - 85,534,711 (-) Ensembl panpan1.1 panPan2
SLC6A15 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 15 26,486,828 - 26,528,885 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 15 26,486,815 - 26,529,483 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 15 26,922,759 - 26,967,810 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 15 26,997,359 - 27,042,704 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 15 26,997,048 - 27,120,117 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 15 26,445,335 - 26,490,617 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 15 26,485,762 - 26,530,970 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 15 26,734,481 - 26,779,780 (-) NCBI UU_Cfam_GSD_1.0
Slc6a15 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 33,747,392 - 33,796,488 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936507 2,438,934 - 2,488,005 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936507 2,438,947 - 2,488,005 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLC6A15 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 5 97,092,925 - 97,148,602 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 5 97,093,197 - 97,148,606 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 5 102,102,525 - 102,136,297 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC6A15 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 80,256,858 - 80,309,272 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 80,256,498 - 80,309,158 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 165,026,030 - 165,093,792 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc6a15 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 426 Count of miRNA genes: 240 Interacting mature miRNAs: 296 Transcripts: ENSRNOT00000029208 Prediction methods: Microtar, Miranda, Targetscan Result types: miRGate_prediction
1354644 Spl4 Serum phospholipid level QTL 4 4.9 blood phospholipid amount (VT:0006084) blood phospholipid level (CMO:0001169) 7 19654317 49753746 Rat 7411569 Bw137 Body weight QTL 137 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 7 21921195 66921195 Rat 9590102 Sffal5 Serum free fatty acids level QTL 5 8.62 0.001 blood free fatty acid amount (VT:0001553) plasma free fatty acids level (CMO:0000546) 7 5329019 50329019 Rat 1578652 Bmd15 Bone mineral density QTL 15 5.2 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 7 9866467 60460686 Rat 1641885 Alcrsp9 Alcohol response QTL 9 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 7 24099606 69099606 Rat 631503 Bp102 Blood pressure QTL 102 1.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 1 44822433 Rat 1549840 Bss5 Bone structure and strength QTL 5 9.8 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 24751841 69751841 Rat 10755438 Coatc9 Coat color QTL 9 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 3529280 48529280 Rat 1300127 Srn1 Serum renin concentration QTL 1 3.87 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 7 29409683 84928080 Rat 2298547 Neuinf5 Neuroinflammation QTL 5 3.7 nervous system integrity trait (VT:0010566) spinal cord Cd74 protein level (CMO:0002131) 7 9462246 58265113 Rat 631513 Scl7 Serum cholesterol level QTL 7 4.1 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 37960569 82960569 Rat 10059592 Kidm45 Kidney mass QTL 45 3.95 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 7 7573985 52573985 Rat 10755440 Coatc10 Coat color QTL 10 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 7496499 52496499 Rat 1354637 Scl30 Serum cholesterol level QTL 30 3.7 blood cholesterol amount (VT:0000180) blood total cholesterol level (CMO:0000051) 7 19654317 49753746 Rat 10755453 Coatc12 Coat color QTL 12 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 31112832 76112832 Rat 1354639 Spl5 Serum phospholipid level QTL 5 3.9 blood LDL phospholipid amount (VT:0010505) blood low density lipoprotein phospholipid level (CMO:0001568) 7 19654317 52888450 Rat 10755451 Coatc11 Coat color QTL 11 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 17944357 62944357 Rat 2317059 Aia15 Adjuvant induced arthritis QTL 15 2.46 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 7 17004598 62004598 Rat 61410 Bw19 Body weight QTL 19 6.2 0.001 body mass (VT:0001259) body weight (CMO:0000012) 7 1 44782185 Rat 7411605 Foco14 Food consumption QTL 14 24.1 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 7 34293282 79293282 Rat 1643004 Pain2 Pain QTL 2 1 mechanical nociception trait (VT:0002734) self mutilation severity score (CMO:0002145) 7 9462246 98011544 Rat 631534 Lnnr1 Liver neoplastic nodule remodeling QTL 1 3.85 0.001 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705) 7 34293282 79293282 Rat 634336 Anxrr17 Anxiety related response QTL 17 3.66 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 924703 115097879 Rat 70190 Mcs6 Mammary carcinoma susceptibility QTL 6 2.29 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 7 26737401 63902784 Rat 1300132 Bp182 Blood pressure QTL 182 3.49 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 7 19654317 84928080 Rat 1300138 Hrtrt9 Heart rate QTL 9 4.72 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 7 29409683 53612950 Rat 10402855 Bp379 Blood pressure QTL 379 0.21 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 29409683 74409683 Rat 738033 Anxrr6 Anxiety related response QTL 6 4.1 exploratory behavior trait (VT:0010471) percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) 7 15573889 60573889 Rat
RH136950
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 38,566,489 - 38,566,707 (+) MAPPER mRatBN7.2 Rnor_6.0 7 45,341,478 - 45,341,695 NCBI Rnor6.0 Rnor_5.0 7 45,362,226 - 45,362,443 UniSTS Rnor5.0 RGSC_v3.4 7 41,511,284 - 41,511,501 UniSTS RGSC3.4 Celera 7 35,514,687 - 35,514,904 UniSTS RH 3.4 Map 7 348.32 UniSTS Cytogenetic Map 7 q21 UniSTS
RH137599
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 38,606,919 - 38,607,098 (+) MAPPER mRatBN7.2 Rnor_6.0 7 45,381,606 - 45,381,784 NCBI Rnor6.0 Rnor_5.0 7 45,402,354 - 45,402,532 UniSTS Rnor5.0 RGSC_v3.4 7 41,551,714 - 41,551,892 UniSTS RGSC3.4 Celera 7 35,556,019 - 35,556,197 UniSTS Cytogenetic Map 7 q21 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
45
113
68
67
36
25
36
6
183
93
93
37
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000029208 ⟹ ENSRNOP00000032996
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 38,553,196 - 38,607,239 (+) Ensembl Rnor_6.0 Ensembl 7 45,328,105 - 45,381,920 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000090641 ⟹ ENSRNOP00000073005
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 7 45,328,162 - 45,382,229 (+) Ensembl
RefSeq Acc Id:
NM_172321 ⟹ NP_758824
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 40,439,750 - 40,493,788 (+) NCBI mRatBN7.2 7 38,553,196 - 38,607,239 (+) NCBI Rnor_6.0 7 45,328,207 - 45,381,920 (+) NCBI Rnor_5.0 7 45,348,955 - 45,402,668 (+) NCBI RGSC_v3.4 7 41,498,013 - 41,552,028 (+) RGD Celera 7 35,501,267 - 35,556,333 (+) RGD
Sequence:
GAATTCCACTTTTGGGGTGGGGGTAAAATAGATATTTTACTTGTGCGATAAGCTCAACAAACGAATAATAGTCCCCGCCTTGGCCTCCACCCACTCCTGTCCTCTTCCCTCTGGAAAGCAGAGCCACC TCTTGGGGAGACCCTGCAGAGTTTGACATCTCAGCCCTCAGTCTTTTAAGTATTTTAACCAAGTGCATCCTCTGATCATTGTGCGATCATTATATTGGCTTTTCTTCATGTTTTTGACTTGCCAGGTG CCTGGCCTGAGAGCTGCAAGAATTACTTCGAAGTTATTTCCCACCCTACAAGTGCGGTATAAATAACCAGACTTAATTTTATTGCATTGTTAAATGTTAGGCCCAAGCTCCAGTTCAAGACAAAGAGG GAGGCTAAGAGATGAGAATCACTTTATTCACTCCAGGCAAAAGCCATGACATAAACCACATATCAGGCAGCCATATGTGGGCACCCAGGCACAGGCTGGTGCACAGACTGAATAAAGGTGAGACCAGC ATGCAGCCTCATAGAAGTAGACACAAAAACTTTACACACACTCACATAACACACACACACACACACACGCACACACACACACACACACACACACGCGCGCGCGCGCCCGCGCGCGCCCCAGGAAACAA ACGCCAGCATCCCGTGCAATATCCTGGCACACACAGGCGCTCACGAGTTTCTCGGTGCCAGCTTGCAGGACAGCGACTCCCGAAACCAAGCCTGCCCTTGGCAAGCTTTCTCTGGTCTCCAGACAGCT CCTCTGCGGCCTCCCGCACCATCACCTGGATCCGACCCTTTCGCCACCTAGGAACCTGGAAGCTCTAAAAGGTGCTGGCTCAAGAAGCACCAGAGGTTGTCTTTAAGAAGAGTAATTTCCAATGCCTA AGAATAGCAAAGTAGTAAAGAGAGATTTGGATGATGATGTCATTGAATCTGTCAAAGACCTCCTGTCCAATGAAGACTCAGTGGAAGATGTTTCTAAGAAGAGCGAACTAATTGTTGATGTTCAAGAA GAGAAAGATACAGATGCTGAAGATGGATCTGAAGTTGATGATGAAAGGCCAGCTTGGAACAGTAAGCTGCAATACATCCTGGCGCAAGTTGGATTTTCTGTAGGTCTGGGGAATGTGTGGCGGTTCCC ATACCTCTGCCAAAAGAATGGCGGTGGTGCATATCTTTTGCCATATTTAATACTACTTCTGGTGATAGGAATTCCACTCTTCTTCTTGGAACTTTCTGTGGGTCAAAGAATTCGGAGAGGCAGCATCG GGGTTTGGAATTACATAAGCCCTAAACTGGGTGGGATTGGATTCGCAAGCTGTGTAGTGTGCTATTTTGTGGCTCTCTACTACAATGTCATCATTGGCTGGACATTGTTTTACTTTTCTCAGTCTTTT CAACAACCTCTCCCTTGGGATCAATGCCCCCTGGTGAAAAACGCATCTCATACTTATATTGAGCCAGAATGTGAAAAAAGTTCTGCCACCACTTATTACTGGTACCGGGAAGCACTGGCTATCAGCAG CTCCATCTCTGAAAGTGGGGGCTTAAACTGGAAGATGACTGGCTGCCTGCTGGCTGCCTGGGTCATGGTTTGTCTGGCCATGATCAAAGGCATTCAGTCCTCTGGAAAAATCATGTATTTTAGTTCTC TGTTCCCCTACGTGGTACTTATATGCTTCCTAATAAGATCTCTCCTTTTAAATGGTTCAATTGATGGCATCCGACACATGTTCACCCCTAAGCTTGAAATGATGCTGGAGCCCAAGGTTTGGAGAGAG GCAGCGACTCAAGTCTTCTTTGCCTTGGGTTTGGGATTTGGTGGAGTCATCGCGTTTTCCAGTTACAACAAGAGAGACAACAACTGCCACTTCGACGCTGTCCTCGTGTCTTTTATCAACTTTTTCAC TTCAGTCCTGGCAACACTGGTGGTGTTCGCAGTTCTGGGGTTCAAAGCCAATATCGTAAATGAAAAGTGCATTTCACAAAATTCTGAGATGATCTTGAAACTTTTGAAAACGGGAAACGTTAGTTGGG ATGTCATTCCCCGTCACATCAACCTTTCAGCTGTCACTGCGGAAGATTATCATGTAGTTTACGACATCATTCAAAAAGTGAAGGAGGAGGAGTTTGCTGTTCTCCATCTCAAAGCCTGTCAAATTGAG GATGAGCTAAATAAAGCTGTGCAGGGCACTGGCTTGGCTTTCATTGCCTTTACAGAGGCCATGACACATTTTCCTGCATCTCCCTTCTGGTCAGTGATGTTTTTCCTCATGCTGATAAATCTCGGGCT CGGCAGCATGTTTGGAACCATTGAAGGAATCATCACTCCTGTTGTGGACACATTCAAAGTGAGGAAGGAAATACTCACCGTTATCTGTTGCCTCCTAGCATTTTGTATCGGCTTGATGTTTGTGCAGC GCTCTGGAAATTACTTCGTTACAATGTTTGATGATTATTCTGCCACATTGCCTCTGTTAATCGTGGTCATCTTGGAGAATATTGCTGTAAGCTTCGTTTACGGCATAGATAAGTTTCTAGAAGACCTA ACAGACATGTTAGGATTTGCTCCAAGCAAATATTACTATTACATGTGGAAATACATTTCTCCTCTAATGCTAGTAACATTGTTAATAGCTAGCATTGTGAATATGGGATTAAGTCCTCCGGGATATAA TGCATGGATCAAGGAGAAGGCATCCGAAGAATTTCTGAGCTACCCGATGTGGGGGATGGTGGTCTGTTTCTCTCTGATGGTGCTGGCTATACTTCCTGTCCCAGTCGTTTTCGTCATTCGTCGCTGCA ACCTCATAGATGATAGTTCTGGTAACTTGGCCTCTGTGACCTATAAGAGAGGAAGAGTCCTGAAAGAACCCGTGAACTTAGACGGAGATGATGCAAGCCTCATTCACGGAAAGATACCAAGTGAAATG TCGTCTCCAAATTTTGGTAAAAATATCTATCGAAAACAGAGTGGTTCTCCGACCCTGGACACTGCTCCCAATGGACGCTATGGGATTGGGTATTTGATGGCAGATATGCCAGATATGCCCGAGTCTGA CTTGTAGCTGAGTGAAAGCAAAGGGTTGAGCTTGGTTCATTTTTATCAATGAGCATTGGTTCTACTATGAGAAGCAGTGAGCTTCACTTGTCACAAGGTGATCTCAGGTGTCCATAGCCGCCATCTTT AATCTCAACAGTTTAAGACAGTTCCAGAAGAGCAATCCTCAGTTTACAATTACAAAGTAACAATTGCAGACAAAGCTTACATTGACTGGGGTCCTTTGCCAGGATTTTTTTAAAAAGCACTTTGACAT ACTTTCAAGTATTTCTATCTCTTAAAAAAAAGGTGTTACCTCAGTTTCTAATAGTTTCCGGATTTAATATTATTGGCGATTTGAAAAAAAAATCCCTGTTATATCTTACAATTCATAATTTTGCCTTC GGAGTAAGTTCCAGTATTACCATGAACAGTTGTGTGTGAGCGGGTGCTTCTCAGCACATTGCCATGAGTACGTTCTGTAGATAGCCTGTACTTATCTTTGGTAGCATTGAAACCTTAGGCACTTAGTT GGAGAAAACTTCAAAGTATTTTCTTATATGATAGCCGTCTAGAGCAATAGTATTAAAGAGTAAAAAGGCACTGATGGTGGATGAGAGGTTAAGTCCAGATGTGATCGAGGGTTTCCTGGAGTGGCCAT ATATTTTGTGTAAAATAGGTGTGTGCAAATGATTGAAGGGACTCTCGAGAATTATGCAGACTGCATTTTTCTTATGCCGTGTGCCTAATAAACCTACTTAATATTTATTGTGGTTTTGAGATCACTTA TAGTATATTTATATAATATACTTGCAATGTATAGAGATGCGCATCAGGACTCTTAAGTGCTGGTTTGAAAACTTGAAGCAAGATAGCATCTGATTTCATATGTTTCTGTTTTGCTTCATTTTATGCAA ATACGAATTCTTTTTTTTAAGTGATTGTTAAAACTGTATGGCATTACATTTTAACCTACAAATAAACGAAGTTTAACA
hide sequence
RefSeq Acc Id:
XM_039078522 ⟹ XP_038934450
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 40,439,607 - 40,493,787 (+) NCBI mRatBN7.2 7 38,553,055 - 38,606,264 (+) NCBI
RefSeq Acc Id:
NP_758824 ⟸ NM_172321
- UniProtKB:
Q63838 (UniProtKB/Swiss-Prot), Q08469 (UniProtKB/Swiss-Prot), A6IGB4 (UniProtKB/TrEMBL)
- Sequence:
MPKNSKVVKRDLDDDVIESVKDLLSNEDSVEDVSKKSELIVDVQEEKDTDAEDGSEVDDERPAWNSKLQYILAQVGFSVGLGNVWRFPYLCQKNGGGAYLLPYLILLLVIGIPLFFLELSVGQRIRRG SIGVWNYISPKLGGIGFASCVVCYFVALYYNVIIGWTLFYFSQSFQQPLPWDQCPLVKNASHTYIEPECEKSSATTYYWYREALAISSSISESGGLNWKMTGCLLAAWVMVCLAMIKGIQSSGKIMYF SSLFPYVVLICFLIRSLLLNGSIDGIRHMFTPKLEMMLEPKVWREAATQVFFALGLGFGGVIAFSSYNKRDNNCHFDAVLVSFINFFTSVLATLVVFAVLGFKANIVNEKCISQNSEMILKLLKTGNV SWDVIPRHINLSAVTAEDYHVVYDIIQKVKEEEFAVLHLKACQIEDELNKAVQGTGLAFIAFTEAMTHFPASPFWSVMFFLMLINLGLGSMFGTIEGIITPVVDTFKVRKEILTVICCLLAFCIGLMF VQRSGNYFVTMFDDYSATLPLLIVVILENIAVSFVYGIDKFLEDLTDMLGFAPSKYYYYMWKYISPLMLVTLLIASIVNMGLSPPGYNAWIKEKASEEFLSYPMWGMVVCFSLMVLAILPVPVVFVIR RCNLIDDSSGNLASVTYKRGRVLKEPVNLDGDDASLIHGKIPSEMSSPNFGKNIYRKQSGSPTLDTAPNGRYGIGYLMADMPDMPESDL
hide sequence
Ensembl Acc Id:
ENSRNOP00000073005 ⟸ ENSRNOT00000090641
Ensembl Acc Id:
ENSRNOP00000032996 ⟸ ENSRNOT00000029208
RefSeq Acc Id:
XP_038934450 ⟸ XM_039078522
- Peptide Label:
isoform X1
- UniProtKB:
Q08469 (UniProtKB/Swiss-Prot), Q63838 (UniProtKB/Swiss-Prot), A6IGB4 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-24
Slc6a15
solute carrier family 6 member 15
Slc6a15
solute carrier family 6 (neutral amino acid transporter), member 15
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-10-23
Slc6a15
solute carrier family 6 (neutral amino acid transporter), member 15
Slc6a15
solute carrier family 6 (neurotransmitter transporter), member 15
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-09-10
Slc6a15
solute carrier family 6 (neurotransmitter transporter), member 15
Ntt73
orphan transporter v7-3
Symbol and Name updated
1299863
APPROVED
2003-02-27
Ntt73
orphan transporter v7-3
Symbol and Name status set to provisional
70820
PROVISIONAL